Pathogenesis of HIV-1 infection within bone marrow cells

Leukemia and Lymphoma

Volumn 37, Issue 5-6, 2000, Pages 497-515

  Kulkosky, Joseph ^a   Bouhamdan, Mohamad ^a   Geist, Aaron ^a   Nunnari, Giuseppe ^a   Phinney, Donald G ^b   Pomerantz, Roger J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow; Cytopenia; Hematopoiesis; HIV 1; Vpr

Indexed keywords

CD4 ANTIGEN; VPR PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; BONE MARROW CELL; CELL DIFFERENTIATION; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTOPENIA; MICROVASCULATURE; MONONUCLEAR PHAGOCYTE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROMA; T LYMPHOCYTE; THROMBOCYTOPENIA; VIRUS CELL INTERACTION; VIRUS REPLICATION; ANIMAL; CELL CULTURE; ERYTHROCYTE; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; MONOCYTE; MOUSE; PANCYTOPENIA; PATHOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; REGULATOR GENE; STROMA CELL; VASCULAR ENDOTHELIUM; VIROLOGY;

ANEMIA; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; FIBROBLASTS; GENE PRODUCTS, VPR; GENES, VPR; GENETIC VECTORS; GLUTATHIONE TRANSFERASE; HIV INFECTIONS; HIV-1; HUMANS; MICE; MONOCYTES; PANCYTOPENIA; PHAGOCYTOSIS; RECOMBINANT FUSION PROTEINS; STROMAL CELLS; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 0034047066     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009058502     Document Type: Review

References (142)

1. Spivak, JL, Bender, BS, and Quinn, TC. Hematological abnormalities in AIDS. Amer. J. Med. 77:225-2128, 1984.
2. Frontiera, M, and Myers, AM. Peripheral blood and bone marrow abnormalities in AIDS. West. J. Med. 147:157-160, 1987.
3. Fauci, AS. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 239:617-622, 1988.
4. Zon, LI, Arkin, C, and Groopman, JE. Hematological manifestations of the human immunodeficiency virus. Brit. J. Hematol. 66:251-256, 1987.
5. Scadden, DT, Zon, LI, and Groopman, JE. Pathophysiology and management of HIV-associated hematological disorders. Blood 74:1455-1463, 1989.
6. Coyle, TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med. Clinics N. Amer. 81:449-463, 1997.
7. Ho, DD, Pomerantz, RJ, and Kaplan, JC. Pathogenesis of infection with human immunodeficiency virus. N. Engl. J. Med. 317:278-286, 1987.
8. Chelucci, C. Federico, M, Guerriero, R, Mattia, G, Casella, I, Pelosi, E, Testa, U, Mariani, G, Hassan, HJ, and Peschle, C. Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 91:1225-1234, 1998.
9. Weichold, FF, Zella, D, Barabitskaja, O, Maciejewski, JP, Dunn, DE, Sloand, EM, and Young, NS. Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infect most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood 91:907-915, 1998.
10. Shen, H, Cheng, T, Preffer, FI, Dombkowski, D, Tomasson, MH, Goland, DE, Yang, O, Hofmann, W, Sodroski, JG, Luster, AD, and Scadden, DT. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite co-receptor expression. J. Virol. 73:728-737, 1999.
11. Potts, BJ, Hoggan, M, Lamperthy, L, and Spivak, J. Replication of HIV-1 and HIV-1 in human bone marrow cultures. Virology 188:840-849, 1992.
12. Chelucci, C, Hassan, JH, Locardi, C, Bulgarini, D, Pelois, E, Mariano, G, Testa, U, Federico, M, Valtieri, M, and Peschle, C. In vitro human immunodeficiency virus-1 infection of purified hematopoietic progenitors in single cell culture. Blood 85:1181-1187, 1995.
13. Lunardi-Iskandar, Y, Georgoulias, V, Bertoli, AM, Augery-Bourget, Y, Ammar, A, Vittecoq, D, Rosenbaum, W, Meyer, P, and Jasmin, C. Impaired in vitro proliferation of hematopoietic precursors in HIV-1-infected subjects. Leuk. Res. 13:573, 1989.
14. Cen, D, Zauli, G, Szarnicki, R, and David, BR. Effect of different human immunodeficiency virus type 1 (HIV-1) isolates on long-term bone marrow haemopoiesis. Br. J. Hematol. 85:596-602, 1993.
15. Neal, TF, Holland, HK, Baum, CM, Villinger, F, Ansari, AA, Sari, R, Wingard, JR, and Fleming. WH. CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 86:1749-1756, 1995.
16. DeLuca, A, Teofili, L, Antinori, A, Iovino, MS, Mencarini, P, Visconti, E, Tamburrini, E, Leone, G, and Ortona, L. Haematopoietic CD34+ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br. J. Haematol. 85:20-24, 1993.
17. Louache, F, Henri, A, Bettaieb, A, Oksenhendler, E, Raguin, G, Tulliez, M, and Vainchenker, W. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 80:2991-2999, 1992.
18. Re, MC, Zauli, G, Gibellini, D, Furlini, G, Ramazzotti, E, Monari, P, Ranieri, S, Capitani, S, and LaPlaca, M. Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS 7:1049-1055, 1993.
19. Stanley, SK, Kessler, SW, Justement, JS, Schnittman, SM, Greenhouse, JJ, Brown, CC, Musongela, L, Musey, K, Kapila, B, and Fauci, AS. CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J. Immunol. 149:689-697. 1992.
20. Davis, BR, Schwartz, DH, Marx, JC, Johnson, CE, Berry, JM, Lyding, J, Merigan, TC, and Zander, A. Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J. Virol. 65:1985-1990, 1991.
21. Vainchenker, W, and Louache, F. Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood 88:4568, 1996.
22. Moses, A, Nelson, J, and Bagby, GC, Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 91:1479-1495, 1998.
23. Vignoli, M, Stecca, B, Furlini, G, Re, MC, Mantovani, V, Zauli, G, Visani, G, Colangeli, V, and LaPlaca, M. Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients. AIDS 12:999-1005, 1998.
24. Nielsen, SD, Ersboll, AK, Mathiesen, L, Nielsen, JO, and Hansen, J-E. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients. J. Infect. Dis. 178:1299-1305, 1998.
25. Finzi, D, Blankson, J, Silicano, JD, Margolick, JB, Chadwick, K, Pierson, T, Smith, K, Lisziewica, J, Lori, F, Flexner, C, Quinn, TC, Chaisson, RE, Rosenberg, E, Walker, B, Gange, S, Gallant, J, and Silicano, RF. Latent infection of CD4+ T cells provide a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Med 5:512-517, 1999.
26. Pomerantz, RJ. Residual HIV-1 disease in the era of highly active antiretroviral therapy. Editorial. N. Engl. J. Med., In Press, 1999.
27. Zhang, H, Dornadula, G, Beumont, M, Livornese, L, Van Uitert, B, Henning, K, and Pomerantz, RJ. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N. Engl. J. Med. 339:1803-9-, 1998.
28. Gill, V, Shattock, J, Scopes, J, Hayes, P, Freedman, AR, Griffin, DE, Gordon-Smith, EC, and Gibson, FM. Human immunodeficiency virus infection impairs hematopoiesis in long-term bone marrow cultures: Non-reversal by nucleoside analogues. J. Infect. Dis. 176:1510-6, 1997.
29. Sloand, EM, Young, NS, Sato, T, Kumar, P, Kim, S, Weichold, FF, and Maciejewski, JP. Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-1-infected patients. AIDS 11:1547-1553, 1997.
30. Lunardi-Iskander, Y, Georgoulias, V, Bertli, AM, Augery-Bourget, Y, Amman A, Vittecoqu, D, Rosenbaum, W, Meyer, P, and Jasmin, C. Impaired in vitro proliferation of hematopoietic precursors in HIV-1-infected subjects. Leuk. Res. 13:573, 1989.
31. Zhao, S-F, Li, W, Dornadula, G, Dicker, D, Hoxie, J, Peiper, SC, Pomerantz, RJ and Duan, L-X. Chemokine receptors and the molecular basis for HIV-1 entry into peripheral hematopoietic stem cells. J. Infect. Dis. 178:1623-1634, 1998.
32. Zauli, G, Furlini, G, Vitale, M, Re, MC, Gibellini, D, Zamai, L, Visano, G, Borgatti, P, Capitano, S. and LaPlaca, M. A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high affinity receptor for human immunodeficiency virus type 1. Blood 84:1896-1905, 1994.
33. Koka, PS, Fraser, JK, Bryson, Y, Bristol, GC, Aldrovandi, GM, Daar, ES, and Zack, JA. Human immunodeficiency virus inhibits multi-lineage hematopoiesis in vivo. J. Virol. 72:5121-5127, 1998.
34. Jenkins, M, Hanley, MB, Moreno, MB, Wieder, E, and McCune, JM. Human immunodeficiency virus-1 infection interrupts thymopaiesis and multi-lineage hematopoiesis in vivo. Blood 91:2672-2678, 1998.
35. Schwartz, GN, Kessler, SW, Rothwell, SW, Burrell, LM, Reid, TJ, Meltzer, MS, Wright, DG. Inhibitory effects of HIV-1-infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow culture. Exp. Hematol. 22:1288, 1995.
36. Moses, AV, Williams, S, Heneveld, ML, Strussenberg, J, Rarick, M, Loveless, M, Bagby, G and Nelson, JA. Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 87:919-925, 1996.
37. Mosca, JD, Kaushal, S, Gartner, S, Kessler, SW, LaRussa, VF, Terwilliger, EF, Kim, JH, Carroll, RG, Hall, ER, Perrera, LP. Yu, Zhipeng, Ritchey, DW, Xu, J, St. Louis, DC, and Mayers, DL. Characterization of a human stromal cell line supporting hematopoietic progenitor cell proliferation: Effect of HIV expression. J. Biomed. Sci. 2:330-342, 1995.
38. Scadden, DT, Zeira M, Woon, A, Wang, Z, Schieve, L, Ikeuchi, K, Lim, B, and Groopman, JE. Human immunodeficiency virus infection of human hone marrow stromal fibroblasts. Blood 76:317-322, 1990.
39. Canque, B, Maradin, A, Rosenzwaig, M, Louache, F, Vainchenker, W, and Gluckman, JC. Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV). Virology 208:779-83, 1995.
40. Sun, NCJ, Shapshak, P, Lachant, NA, Hsu, M-Y, Sieger, L, Schmid, P, Geall, G. and Imagawa, DT. Bone marrow examination in patients with AIDS and AIDS-related complex (ARC). Amer. J. Clin. Pathol. 92:589-594, 1989.
41. Weiser, B, Burger, H, Campbell, P, Donelan, S, and Mladenovic, J. HIV type 1 RNA expression in bone marrows of patients with a spectrum of disease. AIDS Res. and Human Retroviruses 12:1551-1559, 1996.
42. Kitano, K, Abboud, CN, Ryan, DH, Quan, SG, Baldwin, GC, and Golde, DW. Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood 77:1699-1705, 1991.
43. Gill, V, Shattock, RJ, Freedman, AR, et al. Macrophages are the major target cell for HIV infection in long-term bone marrow culture and demonstrate dual susceptibility to lymphocytotropic and monocytotropic strains of HIV-1. Br. J. Hematol. 93:30-7, 1996.
44. Sugiura, K, Oyaizu, N, Pahway, R, Kalyanaraman, VS, and Pahwa, S. Effect of human immunodeficiency virus-1 envelope glycoprotein on in vivo hematopoiesis of umbilical cord blood. Blood 80:1463-1469, 1992.
45. Rameshwar, P, Denny, TN, and Gascon, P. Enhanced HIV-1 activity in bone marrow can lead to myelopoietic suppression partially contributed by gag p24. J. Immunol. 157:4244-4250, 1996.
46. Adams, GB, Pym, AS, Poznansky, MC, McClure, MO, and Weber, JN. The in vivo effects of combination antiretroviral drug therapy on peripheral blood CD34+ cell colony-forming units from HIV type 1 infected patients. AIDS Res and Human Retroviruses 15:551-559, 1999.
47. de Monye, C, Karcher, DS, Boelaert, JR, and Gordeuk, VR. Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS 13:375-380, 1999.
48. Voulgaropoulou, F, Tan, B, Soares, M, Hahn, B, and Ratner, L. Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia. J. Virol. 73:3497-3504, 1999.
49. Slobod, KS, Bennett, TA, Freiden, PJ, Kechli, Am, Howlett, N, Flynn, PM, Head, DR, Srivastava, DK, Boyett, JM, Brenner, MK, and Garcia, JV. Mobilization of CD34+ progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults. Blood 88:3329-3335, 1996.
50. Nielsen, SD, Afzelius, P, Dam-larsen, S, et al. Effect of granulocyte colony-stimulating factor (G-CSF) in human immunodeficieny virus infected patients: increase in numbers of naive CD4 cells and CD34 cells makes G-CSF a candidate for use in gene therapy or to support antiretroviral therapy. J. Inf. Dis. 177:1733-6, 1998.
51. Schooley, R.T., Mladenovic, j., Sevin, A., Chiu, S., Miles, S.A., Pomerantz, R.J., Campbell, T.B., Bell, D., Ambruso, D., Wong, r., Landay, A., Coombs, R.W., Fox, L., Kamoun, M., Jacovini, J., and the ACTG 285 Study Team. A pilot study of CD34+ stem cell mobilization and harvesting from the peripheral blood of persons with HIV-1 infection: reduced mobilization in advanced disease. J. Inf. Dis., in press.
52. Cambell, T., Sevin, A., Coombs, R.W., Peterson, G.C., Rosandich, M., Kuritzkes, D.R., Mladenovic, J., Landay, A., Wong, R., Ambruso, D., Miles, S., Pomerantz, R.J., Schooley, R.T., and the ACTG 285 Study Team. Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of haematopoietic progenitor cells. Blood, in press.
53. Scadden, DT, Pickus, Hammer, SC, Stretcher, B, Bresnahan, J, Gere, J, McGrath, J, and Agosti, JM. Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1. AIDS Res and Human Retroviruses 12:1151-1159, 1996.
54. Groopman, JE, Mitsuyasu, RT, DeLeo, MJ, Oette, DH, and Golde, DW. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N. Eng. J. Med. 317:593-598, 1997.
55. Mondal, D, and Agrawal, KC. Effect of HIV type 1 Tat protein on butyric acid-induced differentiation in a hematopoietic progenitor cell line. AIDS Res and Human Retroviruses 12:1529-1536, 1996.
56. Frazier, ALB, and Garcia, JV. Retrovirus-mediated transfer and long-term expression of HIV type 1 tat gene in murine hematopoietic tissues. AIDS Res and Human Retroviruses 10:1517-1524, 1994.
57. Calenda, V, Graber, P, Delamarter, JF, and Chermann, JC. Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells. Eur. J. Hematol. 52:103-107, 1994.
58. Zauli, G, Vitale, M, Re, MC, Furlini, G, Zamai, L, Falcieri, E., Bihellini, D, Visani, G, Davis, BR, Capitano, S, and LaPlaca, M. In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor dependent TF-1 hematopoietic cell-lines. Blood 83:167-175, 1994.
59. Re, MC, Furlini, G, Zauli, G and LaPlaca, M. Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells. Arch. Virol. 137:1-23, 1994.
60. Zauli, G, Vitale, M, Gibellini, and Capitano, S. Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor β1. J. Exp. Med. 183:99-108, 1996.
61. Zauli, G, Re, MC, Visani, G, Furlini, G, Mazza, P, Vignoli, M, and LaPlaca, M. Evidence for a human immunodeficiency virus type 1-mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J. Infect. Dis. 166:710-6-, 1992.
62. Kaushal, S, LaRussa, VR, Gartner, S, Kessler, S, Perfetto, S, Yu, Z, Ritchey, DW, Xu, J, Perera, P, Kim, J, Reid, T, Mayers, DL, St. Louis, D, and Mosca, JD. Exposure of human CD34+ cells to human immunodeficiency virus type 1 does not influence their expansion and proliferation of hematopoietic progenitors in vitro. Blood 88:130-137, 1996.
63. Wiley, EL, and Nightingale, SD. Opportunistic events and p17 expression in the bone marrow of human immunodeficiency virus-infected patients. J. Infect. Dis. 169:617-20, 1994.
64. Geissler RG, Ganser, A, Ottmann, OG, Gute, P, Morawetz, A, Guba, P, Helm, EB, and Hoelzer, D. In vitro improvement of bone marrow-derived hematopoietic colony formation in HIV-positive patients by alpha-D-tocopherol and erythropoietin. Eur. J. Hematol. 53:201-206, 1994.
65. Steinberg, HN, Crumpacker, CS, and Chatis, PA. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J. Virol. 65:1765-1769, 1991.
66. Stella, CC, Ganser, A. and Hoelzer, D. Defective in vitro growth of the hematopoietic progenitor cells in the acquired immunodeficiency syndrome. J. Clin. Invest. 80:286-293, 1987.
67. Dunahue, RE, Johnson, MM, Zon, LI, Clark, SC, and Groopman, JE. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature 326:200-203, 1987.
68. smm9 infected rhesus macaques with minimal evidence of direct viral infection by polymerase chain reaction. Am. J. Hematol. 43:274, 1993.
69. Kinniburgh, D, and Russell, NH. Comparative study of CD34 positive cells and subpopulations in human umbilical cord blood and bone marrow. Bone Marrow Transplantation 12:489-494, 1993.
70. Steinberg, HN, Anderson, J, Crumpacker, CS, and Chatis, PA. HIV infection of the BS-1 human stroma cells line: effect on murine hematopoiesis. Virology 193:524, 1993.
71. Bagnara, GP, Zauli, G, Giovannini, M, Re, MC, Furlini, G, and LaPlaca, M. Early loss of circulating hematopoietic progenitors in HIV-1-infected subjects. Exp. Hematol. 18:426, 1990.
72. Marandin, A, Canque, B, Coulombel, L, Gluckman, JC, Vainchenker, W, and Louache, F. In vitro infection of bone marrow adherent cells by human immunodeficiency virus type 1 (HIV-1) does not alter their ability to support haemalupoiesis. Virology 213:245-248, 1995.
73. Hoelzer, D, and Ganser, A. Gamma delta-T cell receptor positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type 1-infected patients. AIDS Res Human Retroviruses 12:577, 1996.
74. Bahner, I, Kearns, K, Coutinho, S, Leonard, EH, and Kohn, DB. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood 90:1781, 1997.
75. Esser, R, Glienke, W, Von Briesen, H, Rubsamen-Waigmann, H, and Andreesen, R. Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 88:3474, 1996.
76. Maciejewski, JP, Weichold, FF, and Young, NS. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J. Immunol. 163:4303, 1994.
77. Zauli, G, Davis, BR, Re, MC, Visani, G, Furlini, G, and LaPlaca, M. Tat protein stimulated production of transforming growth factor β1 by marrow macrophages: A potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80:3036, 2992.
78. Maradin, A, Katz, A, Oksenhendler, E, et al. Loss of primitive progenitors in patients with human immunodeficiency virus infection. Blood 88:4568-78, 1996.
79. Kaczmarski, RS, Davison, F, Blair, E, Sutherland, S, Moxhan, J, McManus, T and Mufti, GJ. Detection of HIV in haematopoietic progenitors. Br. J. Haematol. 82:764-769, 1992.
80. Folks, TM, Kessler, SW, Orenstein, JM, Justement, JS, Jaffe, ES, and Fauci, AS. Infection and replication of HIV-1 in purified progenitor cells of normal human hone marrow. Science 242:914-922, 1988.
81. Zauli, G, Vitale, M, Gibellini, D, and Capitini, S. Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1. J. Exp. Med. 183:99, 1996.
82. Alllalio, G, North, M, and Means, RT, Jr. Inhibition of marrow CFU-E colony formation from human immunodeficiency virus infected patients by β- and gamma interferon. Amer. J. Hematol. 53:118, 1996.
83. Emerman, M. 1996. HIV-1, Vpr and the cell cycle. Curr. Biol. 6:1096-1103.
84. Vodicka, M.A., D.M. Koepp, P.A. Silver, and M. Emerman. 1998. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes & Develop. 12:175-185.
85. Connor, R.I., B.K. Chen, S. Choe, and N.R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type 1 in mononuclear phagocytes. Virology 206:935-944.
86. Heinzinger, N., M. Bukrinsky, S. Haggerty, A. Ragland, V. KewalRamani, M. Lee, H. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The HIV-1 Vpr protein influences nuclear targeting of viral nucleic acids in non-dividing cells. Proc. Natl. Acad. Sci. USA. 91:7311-7315.
87. Gallay, P., V. Stitt, C. Mundy, M. Oettinger, and D. Trono. 1996. Role of the karvopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70:1027-1032.
88. Rey, F, BouHamdan, M, Navarro, J-M, Agostini, I, Willetts, K, Bouyac, M, Tamalet, C, Spire, B, Vigne, R, and Sire, J. A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells. J. Gen. Virol. 79:1083-1087, 1998.
89. Vodicka, MA, Koepp, DM, Silver, PA, and Emerman, M. HIV-1 Vpr interacts with the nuclear transport pathway to promote mucrophage infection. Genes & Develop. 12:175-185, 1998.
90. Fouchier, RAM, Meyer, BE, Simon, JHM, Fischer, U, Albright, AV, Gonzalez-Scarano, F, and Malim, MH. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J. Virol. 72:6004-5013, 1998.
91. Popov, S, Rexach, M, Ratner, L, Blobel, G, and Bukrinsky, M, Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J. Biol. Chem. 273:13.347-13352, 1998.
92. 334cdc2-cyclin B.J. Virol. 69:6859-6564.
93. Goh, W-C., M.E. Roger, C.M Kinsey, S.F. Michael, P.N. Fultz, M.A. Nowak, B.H. Hahn, and M. Emerman. 1998. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nature Med. 4:65-71.
94. Jowett, J.B.M., V. Plannelles, B. Poon, N.P. Shah, M-L. Chen, and I.S.Y. Chen. 1995. The human immunodeficiency virus type 1 Vpr gene arrests infected T cells in the G2 M phase of the cell cycle. J. Virol. 69:6304-6313.
95. cdc2 activity. J. Virol. 64:6705-6711.
96. Planelles, V., F. Bachelerie, J.B.M. Jowett, A. Haislip, Y. Xie, P. Banooni, T. Masuda, and I.S.Y. Chen. 1995. Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for Vpr. J. Virol. 69:5883-5889.
97. Roger, M.E., L.I. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 Vpr gene prevents cell proliferation during chronic infection. J Virol. 69:882-88.
98. 2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70:2324-2331.
99. Poon, B., J.B.M. Jowett, S.A. Stewart, R.W. Armstrong, G.M. Rishton, and I.S.Y. Chen. 1997. Human immunodeficiency virus type 1 Vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard. J. Virol. 71:3961-3971.
100. Levy, D.M., L.S. Fernandes, W.V. Williams, and D.B. Weiner. 1993. Induction of cell differentiation by human immunodeficiency virus 1 Vpr. Cell 72:541-550.
101. Yao, X-J, Mouland, AJ, Subbramanian, RA, Forget, J, Rougeau, N, Bergeron, D, and Cohen, EA. Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1 infected dividing Jurkat T cells. J. Virol. 72:4686-4693, 1998.
102. Yao, X-J., R.A. Subramanian, N. Rougeau, F. Boisvert, D. Bergeron, and E.A. Cohen. 1995. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69:7032-7044.
103. Kondo, E., F. Mammano, E.A. Cohen, and H.G. Gottlinger. 1995. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 69:2759-2764.
104. Paxton, W., Connor, R.I., and N.R. Landau. 1993. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67:7229-7237.
105. Felzien, LK, Woffendin, C, Hottiger, MO, Subbramanian, RA, Cohen, EA. and Nabel, GJ. HIV transcriptional activation by the accessory protein, Vpr, is mediated by the p300 co-activator. Proc. Natl. Acad. Sci. USA. 95:5281-5286, 1998.
106. Hrimechi, M, Yao, X-J, Bachand, F, Rougeau, N, and Cohen, EA. Human immunodeficiency virus type 1 (HIV-1) Vpr functions as a immediate early protein during HIV-1 infection. J. Virol. 73:4101-4109, 1999.
107. Levy, D.N.Y. Refaeli, and D.B. Weiner. 1995. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69:1243-1252.
108. Levy, D.N., Y. Refaeli, R.R. MacGregor and D.B. Weiner. 1994. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 91:10873-10877.
109. Refaeli, Y., D.N. Levy, and D.B. Weiner. 1995. The glucocorticoid receptor type II complex is a target of the HIV-1 Vpr gene product. Proc. Natl. Acad. Sci. USA. 92:3621-3625.
110. Bouhamdan, M., S. Benichou, F. Rey, J-M. Navarro, I. Agostini, B. Spire, J. Camonis, G. Slupphaug, R. Vigne, R. Benarous, and J. Sire. 1996. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70:697-704.
111. Gragerov, A, Kino, T, Ilyin-Gragerova, G, Chrousos, GP, and Pavlakis, GN. HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. Virology 245:323-330, 1998.
112. Zhou, Y, Lu, Y, and Ratner, L. Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest. Virology 242:414-424, 1998.
113. Mahalingam, S., S.A. Khan, M.A. Jabbar, C.E. Monken, R.G. Collman, and A. Srinivasan. 1995. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. Virology 207:297-302.
114. DiMarzio, P., S. Choe, M. Ebright, R. Knoblauch, and N.R. Landau. 1995. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:7909-7916.
115. Macreudie, I.G., L.A. Castelli, D.R. Hewish, A. Kirkpatrick, A.C. Ward, and A.A. Azad. 1995. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motif causes cell growth arrest and structural defects. Proc. Natl. Acad. Sci. USA. 92:2770-2774.
116. Mahalingam, S., M. Patel, R.G. Collman and A. Srinivasan. 1995. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. Virology 214:647-652.
117. Mahalingam, S., R.G. Collman, M. Patel, C.E. Monken, and A. Srinivasan, 1995. Role of the conserved dipeptide Gly75 and Cys76 on HIV-1 Vpr function. Virology 210:495-500.
118. Nie, Z. Bergeron, D, Subbramanian, RA, Yao, X-J, Checroune, F, Rougeau, N, and Cohen, EA. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J. Virol. 72:4104-4115, 1998.
119. Poon, B, Grovit-Ferbas, K, Stewart, SA, and Chen, ISY. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 281:266-270, 1998.
120. Zhao, Y., J. Cao, M.R.G. O'Gorman, M. Yu and R. Yogev. 1996. Effect of human immunodeficiency virus type 1 protein R (Vpr) gene expression on basic cellular function of fission yeast schizosaccharomyces pombe. J. Virol. 70:5821-5826.
121. Zhao, Y, Yu, M, Chen, M, Elder, RT, Yamamoto, A, and Cao, J. Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline. Virology 246:266-276, 1998.
122. Stewart, S.A., B. Poon, J.B.M. Jowett, and I.S.Y. Chen. 1997. Human immunodeficiency virus Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:5579-5592.
123. Conti, L, Rainaldi, G, Matarrese, P, Varano, B, Rivabene, R, Columba, S, Sato, A, Belardelli, F, Malorni, W, and Gessani, S. The HIV-1 Vpr protein acts as a negative regulatory of apoptosis in a human lymphoblastoid T cell line: Possible implications for the pathogenesis of AIDS. J. Exp. Med. 187:403-413, 1998.
124. Ayyavoo, V, Mahboubi, A, Mahalingam, S, Ramalingam, R, Kudchodkar, S, Williams, WV, Green, DR, and Weiner, DB. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB. Nature Med. 3:1117-1123, 1997.
125. Lamb, RA, and Pinto, LH. Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life-cycles? Virology 229:1-11, 1997.
126. Piller, SC, Ewart, GD, Premkumar, A, Cox, GB, and Gage, PW. Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc. Natl. Acad. Sci. USA. 93:111-115, 1996.
127. Piller, SC, Ewart, GD, Jans, DA, Gage, PW, und Cox, GB. The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons. J. Virol. 73:4230-4238, 1999.
128. Wu, X., H. Liu, H. Xiao, J. Kim, P. Seshaiah, G. Natsoulis, J.D. Boeke, B.H. Hahn, and J.C. Kappes. 1995. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J. Virol. 69:3389-3398.
129. Fletcher, T.M., M.A. Soares, S. McPhearson, H. Hui, M.A. Wiskerchen, M.A. Muesing, G.M. Shaw, A.D. Leavitt, J.D. Boeke, and B.H. Hahn. 1997. Complementation of integrase function in HIV-1 virions. EMBO J. 16:5123-5138.
130. Wu, X., H. Liu, H. Xiao, J.A. Conway, E. Hunter, and J.C. Kappes. 1997. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO J. 16:5113-5122.
131. Wu, X., H. Liu, H. Xiao, J.A. Conway, and J.C. Kappes. 1996. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles. J. Virol. 3378-3384.
132. Duan L-X, Oakes J, Ferraro A, Bagasra O, and Pomerantz RJ. Tat and rev affect replication of human immunodeficiency virus type 1 in various cells. Virology 199: 474, 1994.
133. Pereira R, Halford KW, O'Hara M, Leeper DB, Sokolov BP, Pollard MD, Bagasra O, and Prockop DJ. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage and lung in irradiated mice. Proc. Natl. Acad. Sci. USA 92: 4857, 1995.
134. Tomida M: Mononuclear Phagocytes: Physiology and Pathology, R.T. Dean and W. Jessup eds: Elsevier, Amsterdam, 1985, p. 243.
135. Turpin J, and Lopez-Berestein G: Mononuclear Phagocytes in Cell Biology, G. Lopez-Berestein and J. Klostergaard eds: CRC Press, Boca Raton, 1993, p. 71.
136. Kulkosky, J. Laptev, A, Shetty, S, Srinivasan, A, BouHamdan, M, D.J. Prockop, and Pomerantz, RJ. HIV-1 Vpr alters bone marrow cell function. Blood, 93:1906-1915, 1999.135.
137. Cen, D., G. Zauli, R. Szarnicki, and Davis, B.R. Effect of different human immunodeficiency virus type-1 (HIV-1) isolates on long-term bone marrow haemopoiesis. Brit. J. of Haemat., 85:596-602.
138. Harbol AW, Liesveld JL, Simpsom-Haidaris J, and Abboud CN. Mechanisms of cytopenia in human immunodeficiency virus infection Blood Rev. 8: 241, 1994.
139. Gowda SD, Stein BS. Mohagheghpour N, Benike CJ, and Engleman EG: Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J. Immunol. 142: 773, 1989.13.
140. Connor RI, Chen BK, Choe S, and Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206: 935, 1995.
141. Hattori N, Michaels F, Fargnoli K, Murcon L, Gallo RC, and Franchini G. The human immunodeficiency virus type 2 Vpr gene is essential for productive infection of human macrophages. Proc. Natl. Acad. Sci. USA 87: 8080, 1940.
142. Campbell BJ, and Hirsch V. Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes J. Virol. 71: 5593, 1997.